Irish medtech firm Gasgon fundraises €2.25m to solve IV infusion issues

The company’s new flagship product, Airvault, is a device for removing air bubbles that negates the need for manual intervention by healthcare staff

Vincent Forde, founder and chief executive of Gasgon, which was last year named the overall winner of the InterTradeIreland Seedcorn Investor Readiness competition. Picture: Kelvin Boyes/Press Eye

Gasgon Medical, a Cork-based medtech company, has raised €2.25 million from investors as it looks to bring its flagship AirVault solution to the market.

Airvault is a device for removing air bubbles that eliminates the need for manual intervention by healthcare staff by automatically capturing air bubbles before they become an issue – saving medical professionals time and preventing intravenous (IV) drug exposure.

IV infusion is the most common invasive procedure in healthcare globally, with ...